These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7702111)

  • 1. Comment: integrating epidemiologic data into risk assessment.
    Wartenberg D; Simon R
    Am J Public Health; 1995 Apr; 85(4):491-3. PubMed ID: 7702111
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and quantitative risk assessment: a bridge from science to policy.
    Hertz-Picciotto I
    Am J Public Health; 1995 Apr; 85(4):484-91. PubMed ID: 7702110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of epidemiology to the study of environmental carcinogens.
    Neuberger JS; Chin TD
    Rev Environ Health; 1984; 4(2):147-59. PubMed ID: 6397791
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiologic data in risk assessment--imperfect but valuable.
    Shore RE
    Am J Public Health; 1995 Apr; 85(4):474-6. PubMed ID: 7702106
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of carcinogen hazard characterisation based on animal studies and epidemiology.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):66-70. PubMed ID: 15667598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific news and epidemiologic editorials: a reply to the critics.
    Feinstein AR
    Epidemiology; 1990 Mar; 1(2):170-80. PubMed ID: 2073508
    [No Abstract]   [Full Text] [Related]  

  • 7. The calculation and use of carcinogenic potency: a review.
    Barr JT
    Regul Toxicol Pharmacol; 1985 Dec; 5(4):432-59. PubMed ID: 3912853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology.
    Egilman D; Howe S
    Int J Occup Environ Health; 2007; 13(1):118-24. PubMed ID: 17427356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of hormesis on the bioassay and hazard assessment of chemical carcinogens.
    Teeguarden JG; Dragan YP; Pitot HC
    Hum Exp Toxicol; 1998 May; 17(5):254-8. PubMed ID: 9663932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflicts between two cultures: implications for epidemiologic researchers in communicating with policy-makers.
    Matanoski GM
    Am J Epidemiol; 2001 Dec; 154(12 Suppl):S36-42. PubMed ID: 11744528
    [No Abstract]   [Full Text] [Related]  

  • 11. [A regulatory view on the article: Risk evaluation of carcinogens and their threshold levels, part I-III].
    Dieter HH; Konietzka R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):921-5. PubMed ID: 16953360
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is the understanding of the scientific basis and the regulatory toxicology associated with the term "not appreciable " in the risk evaluation of carcinogens].
    Dieter HH; Konietzka R; Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Aug; 50(8):1084-5. PubMed ID: 17676413
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer risk-assessment models: anticipated contributions from biochemical epidemiology.
    Alavanja M; Aron J; Brown C; Chandler J
    J Natl Cancer Inst; 1987 Apr; 78(4):633-43. PubMed ID: 3470540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human risk assessment of carcinogens from an administrative perspective.
    Tesseraux I; Lommel A; Ollroge I; Kappos AD; Koss G
    Regul Toxicol Pharmacol; 1990 Feb; 11(1):63-7. PubMed ID: 2184466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk assessment: historical perspectives, current issues, and future directions.
    Velazquez SF; Schoeny R; Rice GE; Cogliano VJ
    Drug Chem Toxicol; 1996 Aug; 19(3):161-85. PubMed ID: 8933022
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology: a foundation of environmental decision making.
    Deener KCK; Sacks JD; Kirrane EF; Glenn BS; Gwinn MR; Bateson TF; Burke TA
    J Expo Sci Environ Epidemiol; 2018 Nov; 28(6):515-521. PubMed ID: 30185947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Truth in packaging?' The unwrapping of epidemiologic research.
    Lanes SF; Poole C
    J Occup Med; 1984 Aug; 26(8):571-4. PubMed ID: 6481496
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.
    Environ Health Perspect; 1986 Aug; 67():201-82. PubMed ID: 3530737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and animal data as a basis for risk assessment.
    Paddle GM
    Arch Toxicol Suppl; 1980; 3():263-9. PubMed ID: 6930946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The linearized multistage model and the future of quantitative risk assessment.
    Crump KS
    Hum Exp Toxicol; 1996 Oct; 15(10):787-98. PubMed ID: 8906427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.